Aspen Insurance (AHL) Upgraded by UBS, Intrexon (XON) Surged

Aspen Insurance Holdings Ltd. (NYSE:AHL)

AHL stock surged $0.64 (or +1.65%) to $39.51 and 1,486,480 shares exchanged hands on Friday's market activity.

AHL was upgraded from Neutral to Buy with price target of $46 by brokerage firm UBS.

AHL recently reported net income after tax of $107.4 million, or $1.43 diluted net income per share, for the third quarter of 2013.

AHL provides reinsurance and insurance coverage to clients in various domestic and global markets through wholly-owned subsidiaries and offices in Bermuda, France, Germany, Ireland, Singapore, Switzerland, the United Kingdom and the United States.

More about Aspen Insurance Holdings Ltd. (NYSE:AHL) at www.aspen.co .

**

Together with its digital network of websites, Crown Equity Holdings Inc. (CRWE) offers advertising branding and marketing services as a worldwide online multi-media publisher.

According to comScore, Inc.'s Video Metrix service, in October 2012 alone, 183 million U.S. internet users watched more than 37 billion online content videos, while "video ad views reached nearly 11 billion."

US Online Video Advertising Spending Growth 2008-2013: 55.9% (2008), 48.5% (2009), 53.3% (2010), 65.2% (2011), 78.9% (2012), 70.6% (2013)

Strategic plans are being developed for CRWE ’s Division CRWETube ( www.crwetube.com ), targeting the multi-billion dollar online video-sharing market.

CRWE ‘s advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness. The company launches, invests and manages select businesses, projects and real estate endeavors.

More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com

**

Intrexon Corporation (NYSE:XON)

Shares of XON jumped $1.68 (or +9.52%) to $19.33 on Friday's trading session, after the company reported strong performance in its financial results compared with last year.

For the third quarter 2013, XON posted total revenues of $6.1 million, an increase of 109.7% compared to $2.9 million in the same period the prior year, and net income attributable to XON of $15.4 million, or $0.15 cents per common share, compared to a net loss of $20.5 million for the third quarter 2012.

XON is a leader in synthetic biology focused on collaborating with companies in Health, Food, Energy and the Environment to create biologically-based products that improve the quality of life and the health of the planet. Through the company's proprietary UltraVector(R) platform, which delivers unprecedented control over the quality, function, and performance of living cells, XON provides its partners with industrial-scale design and development of complex biological systems. XON calls its synthetic biology approach and integrated technologies Better DNA(R).

More about Intrexon Corporation (NYSE:XON) at www.dna.com .

**

Read Full Disclaimer at www.drstockpick.com/disclaimer